Impact and Management of Loss of Eyebrows and Eyelashes.
Alopecia
Eyebrow loss
Eyelash loss
Hair transplant
Madarosis
Management
Quality of life
Treatment
Journal
Dermatology and therapy
ISSN: 2193-8210
Titre abrégé: Dermatol Ther (Heidelb)
Pays: Switzerland
ID NLM: 101590450
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
14
03
2023
accepted:
11
04
2023
medline:
16
5
2023
pubmed:
16
5
2023
entrez:
15
5
2023
Statut:
ppublish
Résumé
Eyelashes and eyebrows have different functions, ranging from practical purposes such as protecting the eye apparatus from external hazards to the definition of our facial expression. For this reason, their loss could have both functional and psychological impact on patients' quality of life. Complete or partial loss can occur any time during life, and identifying the cause is mandatory to establish a correct and prompt treatment. The aim of this paper is to create a practical guide for the management of the most common causes of madarosis to the best of our knowledge.
Identifiants
pubmed: 37188989
doi: 10.1007/s13555-023-00925-z
pii: 10.1007/s13555-023-00925-z
pmc: PMC10264316
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1243-1253Informations de copyright
© 2023. The Author(s).
Références
Thibaut S, De Becker E, Caisey L, Baras D, Karatas S, Jammayrac O, et al. Human eyelash characterization. Br J Dermatol. 2010;162(2):304–10.
pubmed: 19804590
doi: 10.1111/j.1365-2133.2009.09487.x
Nguyen JV. The biology, structure, and function of eyebrow hair. J Drugs Dermatol. 2014;13(1 Suppl):s12–6.
pubmed: 24385126
Vij A, Bergfeld WF. Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis. Clin Dermatol. 2015;33(2):217–26.
Andersen YMF, Nymand L, DeLozier AM, Burge R, Edson-Heredia E, Egeberg A. Patient characteristics and disease burden of alopecia areata in the Danish Skin Cohort. BMJ Open. 2022;12(2): e053137.
pubmed: 35173000
doi: 10.1136/bmjopen-2021-053137
Draelos ZK. Eye cosmetics. Dermatol Clin. 1991;9:1–7.
pubmed: 2022087
doi: 10.1016/S0733-8635(18)30427-3
Jones D. Enhanced eyelashes: prescription and over-the-counter options. Aesthet Plast Surg. 2011;35:116–21.
doi: 10.1007/s00266-010-9561-3
Carruthers J, Carruthers A. Social significance of the eyebrows and periorbital complex. J Drugs Dermatol. 2014;13(1 Suppl):s7–11.
pubmed: 24385129
Smith K, Winstanley J, Boyle F, O’Reilly A, White M, Antill YC. Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy. Support Care Cancer. 2018;26(2):483–9.
pubmed: 28831569
doi: 10.1007/s00520-017-3852-z
Macey J, Kitchen H, Aldhouse NVJ, Edson-Heredia E, Burge R, Prakash A, King BA, Mesinkovska N. A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient-reported outcome measures. Br J Dermatol. 2022;186(5):849–60.
pubmed: 34811721
pmcid: 9305453
doi: 10.1111/bjd.20904
Benton S, Bellefeuille G, Rypka K, Nguyen A, Raymond O, Gorbatenko-Roth K, Maguiness S, Hordinsky MK. Psychosocial impact of pediatric alopecia areata: a survey study. Pediatr Dermatol. 2023. https://doi.org/10.1111/pde.15237 .
doi: 10.1111/pde.15237
pubmed: 36722625
Grandhe NP, Kanwar AJ. Alopecia areata of eyelashes: a subset of alopecia areata. Dermatol Online J. 2004;10(2):13 (PMID: 15530303).
pubmed: 15530303
doi: 10.5070/D307T0791X
Modjtahedi BS, Kishan AU, Schwab IR, Jackson WB, Maibach HI. Eyelash alopecia areata: case series and literature review. Can J Ophthalmol. 2012;47(4):333–8.
pubmed: 22883840
doi: 10.1016/j.jcjo.2012.04.013
Nguyen B, Hu JK, Tosti A. Eyebrow and eyelash alopecia: a clinical review. Am J Clin Dermatol. 2023;24(1):55–67.
pubmed: 36183302
doi: 10.1007/s40257-022-00729-5
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment J Am Acad Dermatol. 2010;62(2):191–202.
pubmed: 20115946
doi: 10.1016/j.jaad.2009.10.031
Rossi A, Muscianese M, Piraccini BM, et al. Italian guidelines in diagnosis and treatment of alopecia areata. G Ital Dermatol Venereol. 2019;154(6):609–23.
pubmed: 31578836
doi: 10.23736/S0392-0488.19.06458-7
Duque Estrada B. A new method to inject the eyebrows. S041 Up-to-date treatment of Hair, Scalp and Nail Disorders. AAD annual meeting, New Orleans (LA). 2023
Daniel BS, Orchard D. Ocular side-effects of topical corticosteroids: what a dermatologist needs to know. Australas J Dermatol. 2015;56(3):164–9.
pubmed: 25754554
doi: 10.1111/ajd.12292
Rudnicka L, Walecka I. Alopecia areata of eyelashes: regrowth after injecting triamcinolone into the eyebrow area. J Am Acad Dermatol. 2009;60(3):AB99.
Barrón-Hernández YL, Tosti A. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia. Expert Opin Investig Drugs. 2017;26(4):515–22.
pubmed: 28264599
doi: 10.1080/13543784.2017.1303480
Borchert M, Bruce S, Wirta D, Yoelin SG, Lee S, Mao C, et al. An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects. Clin Ophthalmol. 2016;10:419–29.
pubmed: 27022239
pmcid: 4792214
Vila TO, Camacho Martinez FM. Bimatoprost in the treatment of eyelash universalis alopecia areata. Int J Trichol. 2010;2(2):86–8.
doi: 10.4103/0974-7753.77511
Coronel-Pérez IM, rodríguez-rey EM, Camacho-martínez FM. latanoprost in the treatment of eyelash alopecia in alopecia areata universalis. J Eur Acad Dermatol Venereol 2010;24:481–5
Ross EK, Bolduc C, Lui H, Shapiro J. Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata. J Am Acad Dermatol. 2005;53(6):1095–6.
pubmed: 16310083
doi: 10.1016/j.jaad.2005.06.031
Roseborough I, Lee H, Chwalek J, Stamper RL, Price VH. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata. J Am Acad Dermatol. 2009;60(4):705–6.
pubmed: 19293023
doi: 10.1016/j.jaad.2008.08.029
Alm A, Grierson I, Shields MB. Side effects associated with prostaglandin analog therapy. Surv Ophthalmol. 2008;53(Suppl 1):S93-105.
pubmed: 19038628
doi: 10.1016/j.survophthal.2008.08.004
Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol. 1983;63(1):49–52.
pubmed: 6191489
Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 1998;39(5Pt1):751–61.
Tosti A, Guidetti MS, Bardazzi F, Misciali C. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis. J Am Acad Dermatol 1996;35(2Pt1):199–201.
Durdu M, Özcan D, Baba M, Seçkin D. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. J Am Acad Dermatol. 2015;72(4):640–50.
pubmed: 25653027
doi: 10.1016/j.jaad.2015.01.008
Craiglow BG. Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes. JAAD Case Rep. 2018;4(10):988–9.
pubmed: 30417059
pmcid: 6218694
doi: 10.1016/j.jdcr.2018.07.018
Kerkemeyer KLS, Sinclair RD, Bhoyrul B. Topical tofacitinib for the treatment of alopecia areata affecting facial hair. Br J Dermatol. 2021;185(3):677–9.
pubmed: 33914907
doi: 10.1111/bjd.20419
Craiglow BG, Tavares D, King BA. Topical ruxolitinib for the treatment of alopecia universalis. JAMA Dermatol. 2016;152(4):490–1.
pubmed: 26649829
doi: 10.1001/jamadermatol.2015.4445
Bokhari L, Sinclair R. Treatment of alopecia universalis with topical Janus kinase inhibitors—a double blind, placebo, and active controlled pilot study. Int J Dermatol. 2018;57(12):1464–70.
pubmed: 30160787
doi: 10.1111/ijd.14192
Dillon KL. A comprehensive literature review of JAK inhibitors in treatment of alopecia areata. Clin Cosmet Investig Dermatol. 2021;14:691–714.
pubmed: 34211288
pmcid: 8242127
doi: 10.2147/CCID.S309215
Sławińska M, et al. Videodermoscopy supports the diagnosis of eyelash trichotillomania. J Eur Acad Dermatol Venereol. 2017;31:e477–8.
pubmed: 28426900
doi: 10.1111/jdv.14294
Atış G, et al. Isolated hair loss on the eyebrow: five cases with trichoscopic features. An Bras Dermatol. 2022;97:372–5.
pubmed: 35272924
pmcid: 9133254
doi: 10.1016/j.abd.2021.04.015
Radmanesh M, et al. Isolated eyebrow and eyelash trichotillomania mimicking alopecia areata. Int J Dermatol. 2006;45:557–60.
pubmed: 16700791
doi: 10.1111/j.1365-4632.2006.02639.x
Torales J, et al. Hair-pulling disorder (trichotillomania): etiopathogenesis, diagnosis and treatment in a nutshell. Dermatol Ther. 2021;34: e13466.
pubmed: 33015928
doi: 10.1111/dth.14366
Aukerman EL, Nakell S, Jafferany M. Psychodynamic approach in the treatment of trichotillomania. Dermatol Ther. 2022;35: e15218.
pubmed: 34816545
doi: 10.1111/dth.15218
Kashetsky N, et al. Efficacy of N-acetylcysteine in trichotillomania (hair-pulling disorder), skin-picking disorder and onychophagia (compulsive nail-biting). JEADV. 2023;37:e73–6.
pubmed: 35964308
Kossard S. Postmenopausal frontal fibrosing alopecia—scarring alopecia in a pattern distribution. Arch Dermatol. 1994;130:770–4.
pubmed: 8002649
doi: 10.1001/archderm.1994.01690060100013
Anzai A, Donati A, Valente NY, Romiti R, Tosti A. Isolated eyebrow loss in frontal fibrosing alopecia: relevance of early diagnosis and treatment. Br J Dermatol. 2016;175(5):1099–101.
pubmed: 27177247
doi: 10.1111/bjd.14750
Vañó-Galván S, Molina-Ruiz AM, Serrano-Falcón C, Arias-Santiago S, Rodrigues-Barata AR, Garnacho-Saucedo G, Martorell-Calatayud A, Fernández-Crehuet P, Grimalt R, Aranegui B, Grillo E, Diaz-Ley B, Salido R, Pérez-Gala S, Serrano S, Moreno JC, Jaén P, Camacho FM. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670–8.
pubmed: 24508293
doi: 10.1016/j.jaad.2013.12.003
Salas-Callo CI, Tosti A, Stohmann D, Contarini P, Pirmez R. Eyelash involvement in frontal fibrosing alopecia: a prospective study. J Am Acad Dermatol. 2022;87(1):232–4.
pubmed: 34403712
doi: 10.1016/j.jaad.2021.07.063
Iorizzo M, Tosti A. Frontal fibrosing alopecia: an update on pathogenesis, diagnosis, and treatment. Am J Clin Dermatol. 2019;20(3):379–90.
pubmed: 30659454
doi: 10.1007/s40257-019-00424-y
Donovan JC, Samrao A, Ruben BS, Price VH. Eyebrow regrowth in patients with frontal fibrosing alopecia treated with intralesional triamcinolone acetonide. Br J Dermatol. 2010;163(5):1142–4.
pubmed: 20716217
doi: 10.1111/j.1365-2133.2010.09994.x
Murad A, Bergfeld W. Prostaglandin analogue for treatment of eyebrow loss in frontal fibrosing alopecia: three cases with different outcomes. J Eur Acad Dermatol Venereol. 2021;35(2):e138–40.
pubmed: 32780892
doi: 10.1111/jdv.16870
Unger W, Unger R, Wesley C. The surgical treatment of cicatricial alopecia. Dermatol Ther. 2008;21:295–311.
pubmed: 18715299
doi: 10.1111/j.1529-8019.2008.00211.x
Audickaite A, Alam M, Jimenez F. Eyebrow hair transplantation in frontal fibrosing alopecia: pitfalls of short- and long-term results. Dermatol Surg. 2020;46(7):922–5.
pubmed: 31652229
doi: 10.1097/DSS.0000000000002207